ResMed Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | $1.93 | $1.93 | $1.93 |
| Q2 2024 | 3 | $2.08 | $2.08 | $2.08 |
| Q3 2024 | 2 | $2.05 | $2.06 | $2.05 |
| Q4 2024 | 6 | $2.28 | $2.35 | $2.32 |
| Q1 2025 | 6 | $2.36 | $2.47 | $2.40 |
| Q2 2025 | 5 | $2.43 | $2.51 | $2.46 |
| Q3 2025 | 5 | $2.37 | $2.46 | $2.41 |
| Q4 2025 | 5 | $2.49 | $2.58 | $2.52 |
| Q1 2026 | 2 | $2.55 | $2.64 | $2.58 |
| Q2 2026 | 2 | $2.59 | $2.68 | $2.63 |
| Q3 2026 | 2 | $2.55 | $2.64 | $2.59 |
| Q4 2026 | 2 | $2.68 | $2.77 | $2.72 |
| Q1 2027 | 2 | $2.72 | $2.82 | $2.76 |
| Q2 2027 | 2 | $2.83 | $2.93 | $2.87 |
ResMed Inc. Earnings Date And Information
ResMed Inc. last posted its earnings results on Thursday, October 24th, 2024. The company reported $2.2 earnings per share for the quarter, topping analysts' consensus estimates of $2.04 by $0.16. The company had revenue of 1.22 B for the quarter and had revenue of 4.69 B for the year. ResMed Inc. has generated $7 earnings per share over the last year ($6.92 diluted earnings per share) and currently has a price-to-earnings ratio of 32.15. ResMed Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, January 22nd, 2025 based on prior year's report dates.
ResMed Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 10/24/2024 | Q1 2025 | $2.12 | $1.19 B | $1.22 B | ||
| 08/08/2024 | Q4 2024 | $1.99 | $1.22 B | $1.22 B | ||
| 04/25/2024 | Q3 2024 | $2.04 | $1.20 B | |||
| 01/24/2024 | Q2 2024 | $1.42 | $1.16 B | |||
| 10/26/2023 | Q1 2024 | $1.49 | $1.10 B | $963.04 M | ||
| 08/10/2023 | Q4 2023 | $1.56 | $1.14 B | $1.12 B | ||
| 04/27/2023 | Q3 2023 | $1.58 | $1.12 B | |||
| 01/26/2023 | Q2 2023 | $1.53 | $1.03 B | |||
| 10/27/2022 | Q1 2023 | $1.44 | $949.78 M | $950.29 M | ||
| 08/11/2022 | Q4 2022 | $1.33 | $910.56 M | $914.74 M | ||
| 04/28/2022 | Q3 2022 | $1.22 | $864.50 M | |||
| 01/27/2022 | Q2 2022 | $1.38 | $894.87 M | |||
| 10/28/2021 | Q1 2022 | $1.40 | $856.61 M | $904.02 M | ||
| 08/16/2021 | Q4 2021 | $1.34 | $799.54 M | $876.10 M | ||
| 04/29/2021 | Q3 2021 | -$0.54 | $768.77 M | |||
| 01/28/2021 | Q2 2021 | $1.24 | $800.01 M | |||
| 10/29/2020 | Q1 2021 | $1.23 | $710.06 M | $751.94 M | ||
| 08/12/2020 | Q4 2020 | $1.23 | $752.04 M | $770.34 M | ||
| 04/30/2020 | Q3 2020 | $1.13 | $769.46 M | |||
| 01/30/2020 | Q2 2020 | $1.11 | $736.16 M |
ResMed Inc. Earnings: Frequently Asked Questions
-
When is ResMed Inc.'s earnings date?
ResMed Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, January 22nd, 2025 based off last year's report dates.
-
Did ResMed Inc. beat their earnings estimates last quarter?
In the previous quarter, ResMed Inc. (:RMD) reported $2.2 earnings per share (EPS) to beat the analysts' consensus estimate of $2.04 by $0.16.
-
How can I listen to ResMed Inc.'s earnings conference call?
The conference call for ResMed Inc.'s latest earnings report can be listened to online.
-
How can I read ResMed Inc.'s conference call transcript?
The conference call transcript for ResMed Inc.'s latest earnings report can be read online.
-
How much revenue does ResMed Inc. generate each year?
ResMed Inc. (:RMD) has a recorded annual revenue of $4.69 B.
-
How much profit does ResMed Inc. generate each year?
ResMed Inc. (:RMD) has a recorded net income of $4.69 B. ResMed Inc. has generated $6.94 earnings per share over the last four quarters.
-
What is ResMed Inc.'s price-to-earnings ratio?
ResMed Inc. (:RMD) has a price-to-earnings ratio of 32.15 and price/earnings-to-growth ratio is 3.54.
